CannTrust™ Holdings Inc. launches the only same-day delivery for medical cannabis in the GTA
‘Trust Delivery Service’ Available to GTA Patients 7-Days-A-Week
VAUGHAN, ON, Feb. 2, 2018 /CNW/ – CannTrust Holdings Inc. (“CannTrust” or the “Company”, CSE: TRST), one of Canada’s leading licensed producers of medical cannabis, announces the launch of a new same-day delivery service for customers in the Greater Toronto Area (the “Trust Delivery Service“).
CannTrust patients in the Greater Toronto Area – from Burlington in the West to Brampton and Aurora in the North and Oshawa in the East – now have the option, for a nominal fee, of choosing guaranteed same-day delivery for orders placed before 4 p.m.
For convenience and confidentiality, the Trust Delivery Service will provide customers with real-time tracking from time of shipment as well as an alert 15 minutes before delivery. Same-day deliveries will be made between 6 p.m. and 10 p.m.
Our decision to launch the Trust Delivery Service in the GTA is a clear example of our customer-centric approach to healthcare. We are committed to providing our customers with the highest quality products and the most convenient and personalized service available.
Brad Rogers, President of CannTrust Inc.
We believe that our Trust Delivery same-day service will give CannTrust a significant competitive advantage in Canada’slargest medical cannabis market. We’re committed to innovation across all aspects of our business, including delivery and customer service. We hope to expand the Trust Delivery Service to other major Canadian centres in the near future.
About CannTrust™
Since its inception in 2014, CannTrust has led the Canadian market in producing pharmaceutically standardized product.
As a federally regulated licensed producer, CannTrust™ brings more than 40 years of pharmacy and healthcare experience to the medical cannabis industry. CannTrust currently operates a 50,000 square foot state-of-the-art hydroponic facility in Vaughan, Ontario, as well as the recently completed 250,000 square foot Phase 1 redevelopment of its 430,000 square foot Niagara Greenhouse Facility. The Phase 2 expansion is underway and is anticipated to be completed and in cultivation towards the middle of 2018.
CannTrust™ is committed to research and innovation, as well as contributing to the growing body of evidence-based research regarding the use and efficacy of cannabis. Our product development teams along with our exclusive global pharma partner, Apotex Inc., are diligently innovating and developing products that will make it easier for patients to use medical cannabis. We support ongoing patient education about medical cannabis and have a compassionate use program to support patients with financial needs.
